Table 1 Differences between unicentric and multicentric intrathoracic CD cases
| Â | UCD | MCD | P |
|---|---|---|---|
Age (mean, years) | 30.44 ± 8.00 | 41.56 ± 13.50 | 0.004 |
Gender | Â | Â | Â |
 Male | 8/50% | 11/34.4% | 0.2967 |
 Female | 8/50% | 21/65.6% | |
Pathological type | Â | Â | Â |
 Hyaline vascular | 3/18.75% | 16/50% |  |
 Plasma cell | 12/75% | 12/37.5% | 0.049 |
 Mixed | 1/6.25% | 4/12.5% |  |
Non-symptomatic | 8/50% | 1/3.1% | <0.001 |
Fever | 0 | 16/50% | <0.001 |
Pleural effusion | 2/12.5% | 13/40.6% | 0.0475 |
Hepatomegaly and/or splenomegaly | 0 | 16/50% | <0.001 |
Anemia | 3/18.8% | 15/46.9% | 0.0578 |
Hemoglobin (g/l) | 133.13 ± 29.70 | 108.66 ± 26.60 | 0.0059 |
Platelet (×10 9 /l) |  |  |  |
 >300 × 109/l | 4/25% | 12/37.5% | 0.6785 |
 <100 × 109/l | 1/8.3% | 2/10% |  |
Hypoalbuminia | 4/25% | 22/68.8% | 0.0041 |
Elevation of serum LDH ‡ | 5/30% | 5/16.1% | 0.6731 |
HIV-Ab | Â | Â | Â |
 Not done | 0 | 6/18.75% |  |
 Negative | 16/100% | 26/100% (n = 26) | 1 |
Chemotherapy cases | 0 | 28/87.5% | <0.001 |
Outcomes | Â | Â | Â |
 Cured | 16/100% | 0 |  |
 Improved | 0 | 18/56.3% |  |
 Stable | 0 | 7/21.9% | <0.001 |
 Died | 0 | 3/9.4% |  |
 Lost follow-up | 0 | 4/12.5% |  |